Moreover, after normalization by the corresponding vehicle-treated group, tumor growth under AZD1775 treatment was highly correlated with ODF2L expression in the ovarian cancer PDX, indicating a role for ODF2L in affecting the response to WEE1 inhibition in EOC (Supplemental Figure 7, A and B). This evidence concerns the gene ODF2L and ovarian cancer.